All Title Author
Keywords Abstract

Marine Drugs  2011 

Aqueous and Methanolic Extracts of Caulerpa mexicana Suppress Cell Migration and Ear Edema Induced by Inflammatory Agents

DOI: 10.3390/md9081332

Keywords: Caulerpa mexicana, green algae, zymosan, inflammation, edema, cell migration

Full-Text   Cite this paper   Add to My Lib

Abstract:

The regulation of the inflammatory response is essential to maintaining homeostasis. Several studies have investigated new drugs that may contribute to avoiding or minimizing excessive inflammatory process. The aim of this study was to evaluate the effect of extracts of green algae Caulerpa mexicana on models inflammation. In mice, the inflammatory peritonitis model is induced by zymosan. Previous treatment of mice with aqueous and methanolic extracts of C. mexicana was able to suppress the cell migration to the peritoneal cavity, in a time-dependent but not in a dose-dependent manner. The treatment of mice with C. mexicana extracts also decreased the xylene-induced ear edema, exerting strong inhibitory leukocyte migration elicited by zymosan into the air pouch. We concluded that administration of the extracts resulted in a reduction of cell migration to different sites as well as a decrease in edema formation induced by chemical irritants. This study demonstrates for the first time the anti-inflammatory effect of aqueous and methanolic extracts from the green marine algae Caulerpa mexicana.

References

[1]  Vuorella, P; Leinonenb, M; Saikkuc, P; Tammelaa, P; Rauhad, JP; Wenneberge, T; Vuorella, H. Natural products in the process of finding new drug candidates. Curr. Med. Chem 2004, 11, 1375–1389.
[2]  Itokawa, H; Morris-Natschke, SL; Akiyama, T; Lee, KH. Plant-derived natural product research aimed at new drug discovery. J. Nat. Med 2008, 62, 263–280.
[3]  Falc?o, HS; Mariath, IR; Diniz, MFFM; Batista, LM; Barbosa-Filho, JM. Plants of the American continent with antiulcer activity. Phytomedicine 2008, 15, 132–146.
[4]  Agra, MF; Silva, KN; Basílio, IJLD; Fran?a, PF; Barbosa-Filho, JM. Survey of medicinal plants used in the region Northeast of Brazil. Braz. J. Pharmacogn 2008, 18, 472–508.
[5]  Sousa, FCF; Melo, CTV; Citó, MCO; Félix, FHC; Vasconcelos, SMM; Fonteles, MMF; Barbosa Filho, JM; Viana, GSB. Medicinal plants and their bioactive constituents: A scientific review of bioactivity and potential benefits in the anxiety disorders in animal models. Braz. J. Pharmacogn 2008, 18, 642–654.
[6]  Barbosa-Filho, JM; Alencar, AA; Nunes, XP; Tomaz, ACA; Sena-Filho, JG; Athayde-Filho, PF; Silva, MS; Souza, MFV; Cunha, EVL. Sources of alpha-, beta-, gamma-, delta- and epsilon-carotenes: a twentieth century review. Braz. J. Pharmacogn 2008, 18, 135–154.
[7]  Quintans-Júnior, LJ; Almeida, JRGS; Lima, JT; Nunes, XP; Siqueira, JS; Oliveira, LEG; Almeida, RN; Athayde-Filho, PF; Barbosa-Filho, JM. Plants with anticonvulsant properties—a review. Braz. J. Pharmacogn 2008, 18, 798–819.
[8]  Falc?o, HS; Leite, JA; Barbosa-Filho, JM; Athayde-Filho, PF; Chaves, MCO; Moura, MD; Ferreira, AL; Almeida, ABA; Souza-Brito, ARM; Diniz, MFFM; et al. Gastric and duodenal antiulcer activity of alkaloids: A review. Molecules 2008, 13, 3198–3223.
[9]  Mota, KSL; Dias, GEN; Pinto, MEF; Luiz-Ferreira, A; Souza-Brito, ARM; Hiruma-Lima, CA; Barbosa-Filho, JM; Batista, LM. Flavonoids with gastroprotective activity. Molecules 2009, 14, 979–1012.
[10]  Mariath, IR; Falc?o, HS; Barbosa-Filho, JM; Sousa, LCF; Tomaz, ACA; Batista, LM; Diniz, MFFM; Athayde-Filho, PF; Tavares, JF; Silva, MS; et al. Plants of the American continent with antimalarial activity. Braz. J. Pharmacogn 2009, 19, 158–192.
[11]  Ribeiro-Filho, J; Falc?o, HS; Batista, LM; Barbosa-Filho, JM; Piuvezam, MR. Effects of plant extracts on HIV-1 protease. Curr. HIV Res 2010, 8, 531–544.
[12]  Silva, FL; Fischer, DCH; Tavares, JF; Silva, MS; Athayde-Filho, PF; Barbosa-Filho, JM. Compilation of Secondary Metabolites from Bidens pilosa L. Molecules 2011, 16, 1070–1102.
[13]  Mayer, AMS; Rodriguez, AD; Berlinck, D; Fusetani, N. Marine pharmacology in 2007–2008: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antiprotozoal, antituberculosis and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C 2011, 153, 191–222.
[14]  Cen-Pacheco, F; Nordstrom, L; Souto, ML; Martin, MN; Fernandez, JJ; Daranas, AH. Studies on polyethers produced by red algae. Mar. Drugs 2010, 8, 1178–1188.
[15]  Guven, KC; Percot, A; Sezik, E. Alkaloids in marine algae. Mar. Drugs 2010, 8, 269–284.
[16]  Cabrita, MT; Vale, C; Rauter, AP. Halogenated compounds from marine algae. Mar. Drugs 2010, 8, 2301–2317.
[17]  Genovese, G; Tedone, L; Hamann, MT; Morabito, M. The mediterranean red alga Asparagopsis: A source of compounds against Leishmania. Mar. Drugs 2009, 7, 361–366.
[18]  O'Sullivan, L; Murphy, B; McLoughlin, P; Duggan, P; Lawlor, PG; Hughes, H; Gardiner, GE. Prebiotics from marine macroalgae for human and animal health applications. Mar. Drugs 2010, 8, 2038–2064.
[19]  Pallela, R; Na-Young, Y; Kim, SK. Anti-photoaging and photoprotective compounds derived from marine organisms. Mar. Drugs 2010, 8, 1189–1202.
[20]  Smith, VJ; Desbois, AP; Dyrynda, EA. Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae. Mar. Drugs 2010, 8, 1213–1262.
[21]  Cantillo-Ciau, Z; Moo-Puc, R; Quijano, L; Freile-Pelegrin, Y. The tropical brown alga Lobophora variegata: A source of antiprotozoal compounds. Mar. Drugs 2010, 8, 1292–1304.
[22]  Iannitti, T; Palmieri, B. An update on the therapeutic role of alkylglycerols. Mar. Drugs 2010, 8, 2267–2300.
[23]  Zhang, JL; Xia, WS; Liu, P; Cheng, QY; Tahirou, T; Gu, WX; Li, B. Chitosan modification and pharmaceutical/biomedical applications. Mar. Drugs 2010, 8, 1962–1987.
[24]  Neto, JTBB; Rodrigues, JAG; Pontes, GC; Farias, WRL. Sulfated polysaccharides of the alga Caulerpa sertularioides (GMEL.) Howe: Analysis of methods of precipitation. Rev. Bras. Eng. Pesca 2008, 3, 50–62.
[25]  Shen, WZ; Wang, H; Guo, GQ; Tuo, JJ. Immunomodulatory effects of Caulerpa racemosa var peltata polysaccharide and its selenizing product on T lymphocytes and NK cells in mice. Sci. China Ser. C 2008, 51, 795–801.
[26]  Torres, MR; Sousa, APA; Silva Filho, EAT; Pessoa, CO; Moraes, MEA; Moraes, MO; Lotufo, LVC. Biological activity of aqueous and organic extracts of seaweeds from Ceará state, Brazil. Arq. Cien. Mar. 2005, 38, 55–63.
[27]  Rocha, FD; Pereira, RC; Kaplan, MAC; Teixeira, VL. Produtos naturais de algas marinhas e seu potencial antioxidante. Braz. J. Pharmacogn 2007, 17, 631–639.
[28]  Ballesteros, E; Martins, D; Uriz, MJ. Biological activity of extracts from some Mediterranean Macrophytes. Bot. Mar 1992, 35, 481–485.
[29]  Cumashi, A; Ushakova, NA; Preobrazhenskaya, ME; D’Incecco, A; Piccoli, A; Totani, L; Tinari, N; Morozevich, GE; Berman, AE; Bilan, MI; et al. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007, 17, 541–552.
[30]  Luster, AD. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med 1998, 338, 436–445.
[31]  Castellheim, A; Brekke, OL; Espevik, T; Harboe, M; Mollnes, TE. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand. J. Immunol 2009, 69, 479–491.
[32]  Shin, DQ; Targan, SR. Immmunopathogeneses of inflammatory bowel disease. World J. Gastroenterol 2008, 21, 390–400.
[33]  Mayer, AMS; Glaser, KB; Cuevas, C; Jacobs, RS; Kem, W; Little, RD; McIntosh, JM; Newman, DJ; Potts, BC; Shuster, DE. The odyssey of marine pharmaceuticals: A current pipeline perspective. Trends Pharmacol. Sci 2010, 31, 255–265.
[34]  Takeuchi, O; Akira, S. Pattern recognition receptors and inflammation. Cell 2010, 140, 805–820.
[35]  Yang, EJ; Moon, JY; Kim, MJ; Kim, DS; Kim, CS; Lee, WJ; Hyun, CG. Inhibition effect of Jeju endemic seaweeds on the production of pro-inflammatory mediators in mouse macrophage cell line Raw 264.7. J. Zhejiang. Univ. Sci. B 2010, 11, 315–322.
[36]  Mollnes, TE; Christiansen, D; Brekke, OL; Espevik, T. Hypothesis: Combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. Adv. Exp. Med. Biol 2008, 632, 253–263.
[37]  Kazlowska, K; Hsu, T; Hou, CC; Yang, WC; Tsai, GJ. Anti-inflammatory properties of phenolic compounds and crude extract from Porphyra dentata. J. Ethanophamacol 2010, 128, 123–130.
[38]  Kolaczkowska, E; Seljelid, R; Plytycz, B. Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice. J. Leukoc. Biol 2001, 69, 33–42.
[39]  Kolaczkowska, E; Koziol, A; Plytycz, B; Arnold, B. Inflammatory macrophages, and not only neutrophils, die by apoptosis during acute peritonitis. Immunobiology 2010, 215, 492–504.
[40]  Souza, ET; Lira, DP; Queiroz, AC; Silva, DJC; Aquino, AB; Mella, EA; Lorenzo, VP; Miranda, GEC; Araújo-Júnior, JX; Chaves, MCO; et al. The antinoceptive and anti-inflammatory activities of caulerpin, a bisindole alkaloid, isolated from seaweeds of the genus Caulerpa. Mar. Drugs 2009, 7, 689–704.
[41]  Souza, ET; Queiroz, AC; Miranda, GEC; Lorenzo, VP; Silva, EF; Freire-Dias, TLM; Cupertino-Silva, YK; Melo, GMA; Santos, BVO; Chaves, MCO; et al. Antinociceptive activities of crude methanolic extract and phases, n-butanolic, chloroformic and ethyl acetate from Caulerpa racemosa (Caulerpaceae). Braz. J. Pharmacogn 2009, 19, 115–120.
[42]  Kelly, MM; Mcnagny, K; Williams, DL; Van Rooijen, N; Maxwell, L; Gwozd, C; Mody, CH; Kubes, P. The lung responds to zymosan in a unique manner independent of toll-like receptors. Am. J. Respir. Cell Mol. Biol 2008, 38, 227–238.
[43]  Ushakova, NA; Preobrazhenskaya, ME; Nifantiev, NE; Usov, AI; Pochechueva, TV; Galanina, OE; Bovin, NV. Inhibitory activity of monomeric and polymeric selectin ligands. Vopr. Med. Khim 1999, 45, 375–383.
[44]  Krieger, M; Herz, J. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem 1994, 63, 601–637.
[45]  Zhang, Z; Luo, P; Li, J; Yi, T; Wang, J; An, J; Zhang, H. Comparison of the anti-inflammatory activities of three medicinal plants known as “Meiduoluomi” in Tibetan folk medicine. Yakugaku Zassi 2008, 128, 805–810.
[46]  Parveen, Z; Deng, Y; Saeed, MK; Dai, R; Ahamad, W; Yu, YH. Antiiflammatory and analgesic activities of Theseus chinese Turcz extracts and its major flavonoids, kaempferol and kaempferol-3-O-glucoside. Pharm. Soc. Jpn 2007, 127, 1275–1279.
[47]  Richardson, JD; Vasko, MR. Cellular mechanisms of neurogenic inflammation. J. Pharmacol. Exp. Ther 2002, 302, 839–845.
[48]  Khan, MN; Choi, JS; Lee, MC; Kim, E; Nam, TJ; Hong, YK. Anti-inflammatory activities of methanol extracts from various seaweed species. J. Environ. Biol 2008, 29, 465–469.
[49]  Yoon, SY; Kwon, YB; Kim, HW; Roh, DH; Kang, SY; Kim, CY; Han, HJ; Kim, KW; Yang, IS; Beitz, AJ; Lee, JH. Intrathecal neostigmine reduces the zymosan-induced inflammatory response in a mouse air pouch model via adrenomedullary activity: Involvement of spinal muscarinic type 2 receptors. Neuropharmacology 2005, 49, 275–282.
[50]  Cabrera, PV; Blanco, G; Gravisaco, MJ; Alvarez, E; Hajos, S. Zymosan modulates CD44 isoform expression in a murine model of inflammation resembling rheumatoid arthritis synovitis. J. Rheumatol 2001, 28, 5943–5949.
[51]  Kim, EH; Shim, B; Kang, S; Jeong, G; Lee, LS; Yu, YB; Chun, M. Anti-inflammatory effects of Scutellaria baicalensis extract via suppression of immune modulators and MAP kinase signaling molecules. J. Ethanopharmacol 2009, 126, 320–331.
[52]  Kang, SY; Yoon, SY; Roh, DH; Jeon, MJ; Seo, HS; Uh, DR; Kwon, YB; Kim, HW; Han, HJ; Lee, HJ; et al. The anti-arthritic effect of ursolic acid on zimosan-induced acute inflammation and adjuvant-induced chronic arthritis models. J. Pharm. Pharmacol 2008, 60, 1347–1354.
[53]  Vigil, SVG; Liz, R; Medeiros, YS; Fr?de, TS. Efficacy of tacrolimus in inhibiting inflammation caused by carrageenan in a murine model of air pouch. Transpl. Immunol 2008, 19, 25–29.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

微信:OALib Journal